Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oxford BioMedica ( (GB:OXB) ) has shared an announcement.
Oxford BioMedica has announced that BlackRock, Inc. has reduced its holding of voting rights in the company to below 5%, following an acquisition or disposal of financial instruments. This change in holdings may impact the company’s shareholder composition but does not appear to affect its current operations or strategic direction significantly.
More about Oxford BioMedica
Oxford BioMedica PLC is a UK-based company operating in the biotechnology sector, focusing on the development and commercialization of gene and cell therapy products and services.
YTD Price Performance: -6.25%
Average Trading Volume: 1,746
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $507.9M
Learn more about OXB stock on TipRanks’ Stock Analysis page.
